Waters Corp  (WAT)
Other Ticker:  
Price: $321.1600 $2.21 0.693%
Day's High: $323.74 Week Perf: -3.22 %
Day's Low: $ 317.04 30 Day Perf: 8.34 %
Volume (M): 10 52 Wk High: $ 428.22
Volume (M$): $ 3,183 52 Wk Avg: $347.09
Open: $325.24 52 Wk Low: $288.32

 Market Capitalization (Millions $) 24,198
 Shares Outstanding (Millions) 75
 Employees 7,500
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 594
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 96

Waters Corp
Waters Corporation, an analytical instrument manufacturer, designs, manufactures and sells, through its Waters Division, high performance liquid chromatography (“HPLC”) and mass spectrometry (“MS”) instrument systems and associated service and support products, including chromatography columns and other “consumable” products. Through its TA Instruments Division (“TAI”), the Company designs, manufactures, services and sells thermal analysis and rheology instruments. The Company is also a developer and supplier of software based products which interface with the Company’s instruments and are typically purchased by customers as part of the instrument system.

The Company’s products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers working in research and development, quality assurance and other laboratory applications. The Company’s HPLC instruments are utilized in this broad range of industries to detect, identify, monitor and measure the chemical, physical and biological composition of materials as well as to purify a full range of compounds. MS instruments are used in drug discovery and development, including clinical trial testing, the analysis of proteins in disease processes (known as “proteomics”) and environmental testing. The Company’s thermal analysis and rheometry instruments are used in predicting the suitability of polymers and viscous liquids for uses in various industrial, consumer goods and health care products.

Waters is a holding company that owns all of the outstanding common stock of Waters Technologies Corporation, its operating subsidiary. The Company previously operated as the Waters Chromatography division of Millipore Corporation, prior to a management buyout of the division that became effective on August 18, 1994. Waters became a publicly traded company with its initial public offering (“IPO”) in November 1995. Since the IPO, the Company has added two significant and complementary technologies to its range of products with the acquisitions of Micromass Limited (“Micromass”) in September 1997 and TAI in May 1996.

The Company operates in the analytical instruments industry, manufacturing and distributing products in three complementary technologies: HPLC, MS and Thermal Analysis. In the third quarter of fiscal year 2003, the Company completed the integration of the Micromass field sales, service distribution and manufacturing organizations into the Waters Division and changed the internal reporting structure to reflect this integration. As a result, the Company has two operating segments, Waters Division and TAI, which have similar economic characteristics, product processes, products and services, types and classes of customers, methods of distribution, and regulatory environments. Because of these similarities, the two segments have been aggregated into one reporting segment for financial statement purposes.


The Company has a broad and diversified customer base that includes pharmaceutical accounts, other industrial accounts, universities and government agencies. The pharmaceutical segment represents the Company’s largest sector and includes multinational pharmaceutical companies, generic drug manufacturers and biotechnology companies. The Company’s other industrial customers include chemical manufacturers, polymer manufacturers, food and beverage companies and environmental testing laboratories. The Company also sells to various universities and government agencies worldwide. The Company’s technical support staff work closely with its customers in developing and implementing applications that meet their full range of analytical requirements.

Sales and Service

The Company has one of the largest sales and service organizations in the industry focused exclusively on HPLC, MS and thermal analysis markets. Across these technologies, using respective specialized sales and service forces, the Company serves its customer base with approximately 1,530 field representatives in 97 sales offices throughout the world. The sales representatives have direct responsibility for account relationships, while service representatives work in the field to install instruments and minimize instrument downtime for customers. Technical support representatives work directly with customers, helping them to develop applications and procedures. The Company provides customers with comprehensive product literature and also makes consumable products available through a dedicated catalog.


The Company provides high quality HPLC products by controlling each stage of production of its instruments and columns. The Company assembles most of its HPLC instruments at its facility in Milford, Massachusetts, where it performs machining, wiring, assembly and testing. The Milford facility employs manufacturing techniques that are expected to meet the strict ISO 9002 quality manufacturing standards and FDA mandated Good Manufacturing Practices. The Company outsources manufacturing of certain electronic components such as computers, monitors and circuit boards to outside vendors that can meet the Company’s quality requirements.

The Company manufactures its HPLC columns at its facilities in Taunton, Massachusetts and Wexford, Ireland, where it processes, sizes and treats silica and polymer media that are packed into columns, solid phase extraction cartridges and bulk shipping containers. The Wexford facility also manufactures and distributes certain data, instruments and software components for the Company’s HPLC, MS and thermal analysis product lines. These facilities meet the same ISO and FDA standards met by the Milford, Massachusetts facility and are approved by the FDA.

The Company manufactures most of its MS products at its facilities in Manchester, England, Cheshire, England and Wexford, Ireland. Certain components or modules of the Company’s MS instruments are manufactured by outside long-standing contractors. Each stage of this supply chain is closely monitored by the Company to maintain its high quality and performance standards. The instruments, components or modules are then returned to the Company’s facilities where its engineers perform final assembly, calibrations to customer specifications and quality control procedures.

Thermal analysis products are manufactured at the Company’s New Castle, Delaware facility and rheology products are manufactured at the Company’s New Castle, Delaware and Leatherhead, England facilities. Similar to MS, certain elements of TAI’s products are manufactured by outside contractors and are then returned to the Company’s facilities for final assembly, calibration and quality control.


The analytical instrument and systems market is highly competitive. The Company encounters competition from several worldwide instrument manufacturers in both domestic and foreign markets for each of its three technologies. The Company competes in its markets primarily on the basis of instrument performance, reliability and service and, to a lesser extent, price. Some competitors have instrument businesses that are more diversified than the Company’s business, but are typically less focused on the Company’s chosen markets. Some competitors have greater financial and other resources than the Company.

In the markets served by HPLC and MS, the Company’s principal competitors include: Applied BioSystems, Inc., Agilent Technologies, Inc., Thermo Electron Corporation, Varian, Inc., Shimadzu Corporation and Bruker BioSciences Corporation. In the markets served by TAI, the Company’s principal competitors include: PerkinElmer Inc., Mettler-Toledo International Inc., Shimadzu Corporation, HAAKE and Parr-Physica.

The market for consumable HPLC products, including separation columns, is also highly competitive but is more fragmented than the analytical instruments market. The Company encounters competition in the consumable columns market from chemical companies that produce column chemicals and small specialized companies that pack and distribute columns. The Company believes that it is one of the few suppliers that process silica, packs columns, and distributes its own product. The Company competes in this market on the basis of reproducibility, reputation and performance, and, to a lesser extent, price. The Company’s principal competitors for consumable products include Phenomenex, Supelco Inc., Agilent Technologies,  Inc., Alltech International Holdings, Inc. and Merck and Co., Inc.

   WAT is expected to report next financial results on August 04, 2022.

Customers Net Income grew by WAT's Customers Net Profit Margin grew to

1887.42 %

3.67 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


Stock Performances by Major Competitors

Year to Date Decrease / Increase
TMO   -13.91%    
B   -28.98%    
DHR   -19.84%    
HON   -8.33%    
JNJ        4.61% 
SRL   -6.47%    
• View Complete Report

Cirtran Corporation

Cirtran Corporation announced first quarter of 2022 operating deficit of $-0.049294 millions

Although company's Sales increased by 11.68% from the same quarter a year ago to $0.69 millions in the first quarter of 2022, Cirtran Corporation increased losses at $-0.11 loss per share.

Vyant Bio Inc.

Redemption of Losses, Sharp Top-line Growth

In the fiscal interval ending Mar 31 2022 Vyant Bio Inc decreased loss of $-0.32 per share compared to $-2.31 a year ago and improved from $-0.85 per share from the previous quarter.

Reed s Inc.

Reed S Inc reported surprisingly strong Top-line advance in the first quarter of 2022 earnings season

Reed S Inc announced in the first quarter of 2022 earnings season surge in Sales by 27.92% to $12.18 millions from the same quarter a year ago, but it has lost money at $-0.05 per share.

Agriforce Growing Systems Ltd.

Losses Widen but Revenues Unchanged

In the first quarter of 2022 Agriforce Growing Systems Ltd increased losses of $-0.22 per share compared to $-0.05 a year ago and increased losses from $-0.14 per share from the previous quarter.

Cemtrex Inc.

Company Fail to Break-even Despite Surge in Sales at Cemtrex Inc in the second quarter of 2022

Company posted a loss at $-0.20 per share in the second quarter of 2022, although its Sales surged by 37.45% to $12.73 millions from the same quarter a year ago.


Waters's Segments
 Segment    67.31 % of total Revenue
 Segment    32.69 % of total Revenue
LC & MS instruments
 Segment    43.79 % of total Revenue
 Segment    15.62 % of total Revenue
TA instruments
 Segment    7.9 % of total Revenue
LC & MS service
 Segment    29.61 % of total Revenue
TA service
 Segment    3.08 % of total Revenue
• View Complete Report
  Company Estimates  
  Revenue Outlook
Waters does not provide revenue guidance.

Earnings Outlook
Cemtrex Inc. does not provide earnings estimates.

Geographic Revenue Dispersion
United States 34.06 %
Europe 34.66 %
Japan 9.33 %
Asia 13.64 %
Other International 8.32 %


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

TXMD's Profile

Stock Price

TXMD's Financials

Business Description


Charts & Quotes

TXMD's News


TXMD's Competitors

Customers & Markets

Economic Indicators

TXMD's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries






About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071